Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest The Scripps Research Institute Stories

1d2dc92bf7dcede4625ef838864284ca1
2010-08-19 11:35:00

Scientists have identified a protein that may bring light to the addictive impact of cocaine on the brain. Researchers said a protein known as methyl CpG binding protein 2 (MeCP2) mixes with a genetic material known as microRNA, which controls a person's motivation to take cocaine. The researchers from the Scripps Research Institute in Florida looked at the expression of MeCP2 in the brain being exposed to cocaine.  During the study, they found the expression was increased in animals...

2010-06-16 23:01:00

PHILADELPHIA, June 17 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today named 21 talented scientists as Pew Scholars in the Biomedical Sciences. The program enables scientists to take calculated risks, expand their research and explore unanticipated leads. Scholars receive $240,000 over four years and gain inclusion into a select community of scientists that includes three Nobel Prize winners, three MacArthur Fellows and two recipients of the Albert Lasker Medical Research Award....

2010-05-21 05:00:00

SAN DIEGO, May 21 /PRNewswire-FirstCall/ -- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus (S. aureus or "Staph") infections, including...

2010-05-19 09:41:50

The results may lead to new approach to therapies for joint disease An international team of scientists from The Scripps Research Institute in California and the National Research Institute for Child Health and Development in Japan has discovered that a natural molecule in the body counters the progression of osteoarthritis. The findings could one day lead to new therapies for some common diseases of aging. The study was published in an advanced, online issue of the journal Genes &...

24945590b3841f4f2b2eb3a98dbfaba81
2010-04-13 16:52:15

La Jolla, CA -- Two chemists at The Scripps Research Institute have synthesized a new nano-scale scientific tool "” a tiny molecular switch that turns itself on or off as it detects metallic ions in its immediate surroundings. Featured on the cover of the April 19, 2010 issue of the International Edition of the journal Angewandte Chemie, this molecule may be useful as a laboratory tool for controlling tiny reactions in the test tube, and it has potential to be developed as the basis of...

2010-04-13 08:49:50

The groundbreaking new findings will speed research on potential therapies Scientists at The Scripps Research Institute have solved the decade-old mystery of why human embryonic stem cells are so difficult to culture in the laboratory, providing scientists with useful new techniques and moving the field closer to the day when stem cells can be used for therapeutic purposes. The research is being published in the journal Proceedings of the National Academy of Sciences (PNAS) during the week of...

2010-03-17 13:58:00

JUPITER, Fla., March 17 /PRNewswire/ -- Recent laboratory experiments which seek to recreate the formation of the first living cells from the basic chemical building blocks of nature are shedding new light on how life may have occurred on earth and on other planets, biologist Jack Szostak and chemist Brian Paegel said late yesterday in the annual Lasker Foundation Lecture on the Florida campus of the Scripps Research Institute. In his remarks, "The Origin of Cellular Life and the...

2010-02-08 08:15:00

DENVER and NEW ORLEANS, Feb. 8 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that will generate an additional $800,000 in contract revenue for Corgenix over the life of the contract. The National Institutes of Health (NIH) has awarded a five-year contract...

2010-01-11 07:00:00

SAN DIEGO, Jan. 11 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA. Under the terms of the agreement, Sorrento Therapeutics obtains an exclusive, worldwide license to the Institute's novel technology, based on quorum sensing, for the prevention and treatment of Staphylococcus aureus ('Staph') infections, including Methicillin-resistant Staph. aureus...

2010-01-01 10:42:26

Research may point to more effective therapeutic targets for deadly prion diseases Scientists from The Scripps Research Institute have determined for the first time that prions, bits of infectious protein devoid of DNA or RNA that can cause fatal neurodegenerative disease, are capable of Darwinian evolution. The study from Scripps Florida in Jupiter shows that prions can develop large numbers of mutations at the protein level and, through natural selection, these mutations can eventually...